$DAO

Youdao (DAO) Q2 2026 Earnings Call Transcript

Youdao (DAO) reported Q2 2026 revenue of RMB 1.5 billion, up 3.5% YoY. Learning services revenue grew 20.9%, while smart devices revenue fell 31.5%. Net income was RMB 73.8 million, reversing last year's loss. Management highlighted AI-driven growth and cost pressures in smart devices.

Original reporting
Published Aug 27, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 2:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Youdao (DAO) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$DAOBullishHigh
01

Why it matters

Earnings beat and a $33.8M share repurchase suggest strong cash generation and management confidence, likely supporting short‑term price gains.

02

Market read

First‑time profit and solid top‑line growth make this a high‑impact earnings event for DAO.

03

What to watch

Potential headwinds from rising memory costs and regulatory scrutiny in China.

Relevance 7/10Novelty 8/10Timing: post‑earnings release today

Background

Youdao (DAO) disclosed its Q2 2026 financial results, marking the eighth consecutive quarter of operating profitability.

Company-level read

Ticker impact

$DAOBullishHigh confidence
Context

Q2 2026 earnings release with net revenue of $216.2M, operating profit up 2.9x and net income turning positive.

Expected impact

Potential upside of 5‑10% on the day of release.

Evidence & confidence

First‑time profit, revenue growth in learning services and AI, and a sizable share repurchase signal confidence.

Market effects

AI‑driven education and online marketing segments may see broader interest.

Positive for Chinese tech ADRs and AI‑focused stocks.

Limited to investors tracking AI education services.

Counterpoint

Margin compression in smart devices and modest revenue size could limit upside.

Key entities

  • Feng Zhou

    Provided commentary on AI product rollout and future growth.

  • Jeffrey Wang

    Led the earnings call and highlighted financial highlights.

Related articles

$DAOHighAI 8/10

Youdao shares rise as Q2 earnings beat offsets revenue shortfall

Youdao (NYSE: DAO) shares rose 1.86% premarket after Q2 earnings of RMB0.76 per ADS beat estimates, though revenue of RMB1.47B missed forecasts. Profitability improved with net income of RMB73.8M and gross margin expansion to 48.9%. Learning services revenue grew 20.9%, while smart devices and online marketing declined.

$DAOHigh

Youdao, Inc. (DAO): Financial results for Q2 2026

Youdao, Inc. (DAO) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 For investor and media inquiries, please contact: In China: Jeffrey Wang Youdao, Inc. Tel: +86-10-8255-8163 ext. 89980 E-mail: IR@rd.netease.com Piacente Financial Communications Helen Wu Tel: +86-10-6508-0677 E-mail: youdao@thepiacentegroup.com In the United States:

$DAOHighAI 8/10

Youdao Reports Second Quarter 2026 Unaudited Financial Results

Youdao (NYSE: DAO) reported Q2 2026 revenue of RMB1.5B (US$216.2M), up 3.5% YoY. Learning services revenue grew 20.9%, while smart devices and online marketing services declined 31.5% and 7.7%, respectively. Gross margin improved to 48.9% from 43.0%. Net income was RMB73.8M (US$10.9M), a turnaround from a loss in Q2 2025. CEO Dr. Feng Zhou highlighted sustainable growth and AI-driven progress.

Med

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

$MDTMedAI 8/10

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.